Recruiting

Blood Flow Restriction Training

Sponsor:

Casa Colina Hospital and Centers for Healthcare

Code:

NCT06535373

Conditions

Healthy Volunteers

Eligibility Criteria

Sex: All

Age: 18 - 35

Healthy Volunteers: Accepted

Interventions

Blood flow restriction

Study Details

Brief summary:

The primary objective of this prospective study is to investigate the effects of Blood Flow Restriction (BFR) training compared to traditional low-weight resistance training on grip strength in young adults.

Despite the growing interest in BFR training and its potential benefits, there is limited research specifically investigating its impact on grip strength. Understanding the effects of BFR training on grip strength could have significant implications for individuals seeking to optimize their grip performance, rehabilitation settings, and sports performance enhancement. Additionally, examining the safety and efficacy of BFR training for this specific outcome will contribute valuable insights to the scientific community.

Conditions

Healthy Volunteers

Study ID

NCT06535373

Start date

Aug 19, 2024

Status verified date

Oct, 2024

Completion date

Dec, 2025

Anticipated

Primary completion date

Aug, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 35

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Participants must be between 18 and 35 years old at the time of enrollment.

Participants should be in good general health with no known cardiovascular, musculoskeletal, or neurological disorders that could interfere with exercise participation.

Participants must provide informed consent before enrollment in the study, indicating their willingness to participate voluntarily.

Exclusion Criteria:

  • Participants with a history of cardiovascular disease (e.g., heart disease, hypertension), musculoskeletal injuries (e.g., fractures, dislocations), or neurological disorders (e.g., neuropathy) that could affect exercise performance will be excluded.

Participants taking medications or supplements that may impact muscle strength, metabolism, or blood flow will be excluded from the study.

Pregnant individuals will be excluded due to potential risks associated with exercise and blood flow restriction during pregnancy.

Individuals with recent upper extremity injuries, such as strains, sprains, or fractures, will be excluded until fully recovered.

Blood Pressure: Participants with uncontrolled high blood pressure or other medical conditions affecting vascular health may be excluded due to potential risks associated with blood flow restriction.

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Blood flow restriction with low-weight resistance training (LWRT) group

a blood flow restriction with low-weight resistance training (LWRT) group

no intervention: No Blood flow restriction group which just does LWRT

a non blood flow restriction group which just does low-weight resistance training

Interventions

Blood flow restriction

Both groups will undergo a 6-week training intervention with training 2x a week, after which grip strength and other relevant outcomes will be measured and compared. Exercise sessions will be at least 48 hours apart. Participants will be allowed to continue with their normal exercise routine outside of the study.

Primary outcome measure

  • Grip Strength [ Time Frame: baseline, post-intervention (6 weeks), and follow-up (6 weeks) ]

Central Contacts and Locations

Locations

Casa Colina Healthcare and Hospital

Recruiting

Pomona, California, United States, 91767

Contacts

Principal Investigator:

Emily Rosario, PhD

More Information

Sponsor

Casa Colina Hospital and Centers for Healthcare

Last update posted

Oct 15, 2024

Last verified

Oct, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Casa Colina Hospital and Centers for Healthcare on 2024-10-15.